A judge in a Texas widow's lawsuit over Merck & Co.'s Vioxx drug has reduced a $32 million jury verdict to about $7.75 million, citing Texas' recently enacted caps on punitive damages. A spokesman for Merck's outside law firm said Merck is seeking a new trial based on "the undisclosed financial relationship" between the plaintiff and a juror.
December 22, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A judge in a Texas widow’s lawsuit regarding the Merck & Co. drug Vioxx has reduced a $32 million jury verdict to about $7.75 million, citing Texas’ recently enacted caps on punitive damages.
A spokesman for Merck’s outside legal counsel said the company was seeking a new trial based on “the undisclosed financial relationship” between the plaintiff and one of the jurors.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
